JPMorgan Chase & Co’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.32M | Buy |
310,547
+262,805
| +550% | +$6.19M | ﹤0.01% | 2432 |
|
|
2025
Q1 | $1.15M | Sell |
47,742
-173,743
| -78% | -$4.17M | ﹤0.01% | 3580 |
|
|
2024
Q4 | $9.37M | Buy |
221,485
+92,390
| +72% | +$3.91M | ﹤0.01% | 2283 |
|
|
2024
Q3 | $5.71M | Sell |
129,095
-4,679
| -3% | -$207K | ﹤0.01% | 2561 |
|
|
2024
Q2 | $4.84M | Sell |
133,774
-201,790
| -60% | -$7.3M | ﹤0.01% | 2545 |
|
|
2024
Q1 | $14.5M | Buy |
335,564
+304,219
| +971% | +$13.1M | ﹤0.01% | 1898 |
|
|
2023
Q4 | $482K | Buy |
31,345
+8,284
| +36% | +$127K | ﹤0.01% | 3933 |
|
|
2023
Q3 | $316K | Sell |
23,061
-3,170
| -12% | -$43.5K | ﹤0.01% | 3962 |
|
|
2023
Q2 | $421K | Buy |
26,231
+9,589
| +58% | +$154K | ﹤0.01% | 3851 |
|
|
2023
Q1 | $129K | Sell |
16,642
-97,340
| -85% | -$755K | ﹤0.01% | 4546 |
|
|
2022
Q4 | $2.21M | Buy |
113,982
+38,652
| +51% | +$748K | ﹤0.01% | 2897 |
|
|
2022
Q3 | $1.61M | Sell |
75,330
-23,606
| -24% | -$503K | ﹤0.01% | 3066 |
|
|
2022
Q2 | $1.35M | Sell |
98,936
-50,665
| -34% | -$690K | ﹤0.01% | 3279 |
|
|
2022
Q1 | $3.51M | Buy |
149,601
+73,475
| +97% | +$1.73M | ﹤0.01% | 2802 |
|
|
2021
Q4 | $2.04M | Sell |
76,126
-2,526
| -3% | -$67.5K | ﹤0.01% | 3220 |
|
|
2021
Q3 | $1.37M | Buy |
+78,652
| New | +$1.37M | ﹤0.01% | 3413 |
|